These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30300141)

  • 141. Immunotherapeutics in Multiple Myeloma: How Can Translational Mouse Models Help?
    Cooke RE; Koldej R; Ritchie D
    J Oncol; 2019; 2019():2186494. PubMed ID: 31093282
    [TBL] [Abstract][Full Text] [Related]  

  • 142. PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation.
    Armand P; Chen YB; Redd RA; Joyce RM; Bsat J; Jeter E; Merryman RW; Coleman KC; Dahi PB; Nieto Y; LaCasce AS; Fisher DC; Ng SY; Odejide OO; Freedman AS; Kim AI; Crombie JL; Jacobson CA; Jacobsen ED; Wong JL; Patel SS; Ritz J; Rodig SJ; Shipp MA; Herrera AF
    Blood; 2019 Jul; 134(1):22-29. PubMed ID: 30952672
    [TBL] [Abstract][Full Text] [Related]  

  • 143. Autologous graft versus myeloma: it's not a myth.
    Dong S; Ghobrial IM
    J Clin Invest; 2019 Jan; 129(1):48-50. PubMed ID: 30457981
    [TBL] [Abstract][Full Text] [Related]  

  • 144. Effector memory and central memory NY-ESO-1-specific re-directed T cells for treatment of multiple myeloma.
    Schuberth PC; Jakka G; Jensen SM; Wadle A; Gautschi F; Haley D; Haile S; Mischo A; Held G; Thiel M; Tinguely M; Bifulco CB; Fox BA; Renner C; Petrausch U
    Gene Ther; 2013 Apr; 20(4):386-95. PubMed ID: 22739387
    [TBL] [Abstract][Full Text] [Related]  

  • 145. Homing characteristics of donor T cells after experimental allogeneic bone marrow transplantation and posttransplantation therapy for multiple myeloma.
    van der Voort R; Volman TJ; Verweij V; Linssen PC; Maas F; Hebeda KM; Dolstra H
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):378-86. PubMed ID: 23266741
    [TBL] [Abstract][Full Text] [Related]  

  • 146. Immunotherapy of multiple myeloma.
    Minnie SA; Hill GR
    J Clin Invest; 2020 Apr; 130(4):1565-1575. PubMed ID: 32149732
    [TBL] [Abstract][Full Text] [Related]  

  • 147. Bone marrow transplantation generates T cell-dependent control of myeloma in mice.
    Vuckovic S; Minnie SA; Smith D; Gartlan KH; Watkins TS; Markey KA; Mukhopadhyay P; Guillerey C; Kuns RD; Locke KR; Pritchard AL; Johansson PA; Varelias A; Zhang P; Huntington ND; Waddell N; Chesi M; Miles JJ; Smyth MJ; Hill GR
    J Clin Invest; 2019 Jan; 129(1):106-121. PubMed ID: 30300141
    [TBL] [Abstract][Full Text] [Related]  

  • 148. Myeloma escape after stem cell transplantation is a consequence of T-cell exhaustion and is prevented by TIGIT blockade.
    Minnie SA; Kuns RD; Gartlan KH; Zhang P; Wilkinson AN; Samson L; Guillerey C; Engwerda C; MacDonald KPA; Smyth MJ; Markey KA; Vuckovic S; Hill GR
    Blood; 2018 Oct; 132(16):1675-1688. PubMed ID: 30154111
    [TBL] [Abstract][Full Text] [Related]  

  • 149. High somatic mutation and neoantigen burden are correlated with decreased progression-free survival in multiple myeloma.
    Miller A; Asmann Y; Cattaneo L; Braggio E; Keats J; Auclair D; Lonial S; ; Russell SJ; Stewart AK
    Blood Cancer J; 2017 Sep; 7(9):e612. PubMed ID: 28937974
    [TBL] [Abstract][Full Text] [Related]  

  • 150. Chromatin states define tumour-specific T cell dysfunction and reprogramming.
    Philip M; Fairchild L; Sun L; Horste EL; Camara S; Shakiba M; Scott AC; Viale A; Lauer P; Merghoub T; Hellmann MD; Wolchok JD; Leslie CS; Schietinger A
    Nature; 2017 May; 545(7655):452-456. PubMed ID: 28514453
    [TBL] [Abstract][Full Text] [Related]  

  • 151. Acute graft-versus-host disease is regulated by an IL-17-sensitive microbiome.
    Varelias A; Ormerod KL; Bunting MD; Koyama M; Gartlan KH; Kuns RD; Lachner N; Locke KR; Lim CY; Henden AS; Zhang P; Clouston AD; Hasnain SZ; McGuckin MA; Blazar BR; MacDonald KP; Hugenholtz P; Hill GR
    Blood; 2017 Apr; 129(15):2172-2185. PubMed ID: 28137828
    [TBL] [Abstract][Full Text] [Related]  

  • 152. Novel functions for the transcription factor E2F4 in development and disease.
    Hsu J; Sage J
    Cell Cycle; 2016 Dec; 15(23):3183-3190. PubMed ID: 27753528
    [TBL] [Abstract][Full Text] [Related]  

  • 153. Spontaneous onset and transplant models of the Vk*MYC mouse show immunological sequelae comparable to human multiple myeloma.
    Cooke RE; Gherardin NA; Harrison SJ; Quach H; Godfrey DI; Prince M; Koldej R; Ritchie DS
    J Transl Med; 2016 Sep; 14(1):259. PubMed ID: 27599546
    [TBL] [Abstract][Full Text] [Related]  

  • 154. Multiple myeloma causes clonal T-cell immunosenescence: identification of potential novel targets for promoting tumour immunity and implications for checkpoint blockade.
    Suen H; Brown R; Yang S; Weatherburn C; Ho PJ; Woodland N; Nassif N; Barbaro P; Bryant C; Hart D; Gibson J; Joshua D
    Leukemia; 2016 Aug; 30(8):1716-24. PubMed ID: 27102208
    [TBL] [Abstract][Full Text] [Related]  

  • 155. Immune responses in multiple myeloma: role of the natural immune surveillance and potential of immunotherapies.
    Guillerey C; Nakamura K; Vuckovic S; Hill GR; Smyth MJ
    Cell Mol Life Sci; 2016 Apr; 73(8):1569-89. PubMed ID: 26801219
    [TBL] [Abstract][Full Text] [Related]  

  • 156. Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myeloma.
    Prabhala RH; Fulciniti M; Pelluru D; Rashid N; Nigroiu A; Nanjappa P; Pai C; Lee S; Prabhala NS; Bandi RL; Smith R; Lazo-Kallanian SB; Valet S; Raje N; Gold JS; Richardson PG; Daley JF; Anderson KC; Ettenberg SA; Di Padova F; Munshi NC
    Leukemia; 2016 Feb; 30(2):379-89. PubMed ID: 26293646
    [TBL] [Abstract][Full Text] [Related]  

  • 157. Boosting Cancer Immunotherapy with Anti-CD137 Antibody Therapy.
    Yonezawa A; Dutt S; Chester C; Kim J; Kohrt HE
    Clin Cancer Res; 2015 Jul; 21(14):3113-20. PubMed ID: 25908780
    [TBL] [Abstract][Full Text] [Related]  

  • 158. Immunosurveillance and therapy of multiple myeloma are CD226 dependent.
    Guillerey C; Ferrari de Andrade L; Vuckovic S; Miles K; Ngiow SF; Yong MC; Teng MW; Colonna M; Ritchie DS; Chesi M; Bergsagel PL; Hill GR; Smyth MJ; Martinet L
    J Clin Invest; 2015 May; 125(5):2077-89. PubMed ID: 25893601
    [TBL] [Abstract][Full Text] [Related]  

  • 159.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 160.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.